Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Equitix in connection with its acquisition of Brotorp wind park
Mandate

Vinge advises Equitix in connection with its acquisition of Brotorp wind park

February 28, 2020 M&A Energy

Vinge has advised Equitix in conjunction with the acquisition of all shares in Brotorp Power AB, which owns and operates the 46.2 MW Brotorp wind park in Mönsterås Municipality, from BlackRock.

Vinge’s team was headed by M&A partner Peter Sundgren and included, inter alia, partners Johan Cederblad and Thomas Sjöberg (real estate and environment), Christoffer Thalin (M&A); counsel Sofia Törnroth Nyberg (project financing); associates Rasmus Perdahl (M&A), Hannah Kajlinger (M&A), Hannes Pettersson (M&A), Jolinn Uhlin (project financing), Martin Cronsioe (real estate) and Karolina Cohrs (real estate); and project assistant Jessica Öijer.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026